Dr. Phillip Frost is the chairman and CEO at OPKO Health, Inc., a biopharmaceutical and diagnostics company.
Dr. Frost was born in Philadelphia in 1936. He earned his undergraduate degree at the University of Pennsylvania, and his M.D. at the Albert Einstein College of Medicine.
Following university, he served as a lieutenant commander for the U.S. Public Health Service at the National Cancer Institute. He then worked as a dermatology professor at the University of Miami School of Medicine, and later served as chair of Mt. Sinai Medical Center’s dermatology department.
Frost joined Key Pharmaceuticals in 1972, where he reformulated its asthma drug and then sold the company for $836 million in 1986. He served as chair and CEO for generic drugmaker, Ivax, from 1987 to 2006, when it was acquired by Teva Pharmaceutical Industries. He sat on Teva’s board until 2015.
Presently, Dr. Frost serves as OPKO Health’s CEO, a role he has held since 2007. The company is involved in the discovery, development, and commercialization of pharmaceutical products, vaccines, and diagnostic products.
Dr. Frost is also a director of Cocrystal Pharma, Inc., a publicly traded biotechnology company developing new treatments for viral diseases.
In September 2018, the SEC accused Dr. Frost of participating in a "pump-and-dump" scheme that generated over $27 million in unlawful stock sales. He settled in December 2018 without admitting or denying the allegations.
Dr. Frost sits on numerous boards and has a long history of philanthropy. His financial gifts include a $33 million donation to the University of Miami School of Music in 2003, then the largest gift to a university music school in the U.S. The school was subsequently renamed the Phillip and Patricia Frost School of Music. In 2011, he gave $35 million for the construction of a new building for the Miami Science Museum, to be named the Patricia & Phillip Frost Science Museum, and in 2015, he gave an additional $10 million toward the museum’s Frost Planetarium.
He is married to Patrica Orr, and they live on Star Island, Miami Beach.
What is Phillip Frost's net worth?
The estimated net worth of Phillip Frost is at least $505.28 million as of June 21st, 2022. Dr. Frost owns 196,606,694 shares of OPKO Health stock worth more than $505,279,204 as of June 29th. This net worth evaluation does not reflect any other assets that Dr. Frost may own. Additionally, Dr. Frost receives an annual salary of $971,600.00 as CEO at OPKO Health. Learn More about Phillip Frost's net worth.
How old is Phillip Frost?
What is Phillip Frost's salary?
As the CEO of OPKO Health, Inc., Dr. Frost earned a total compensation package of $1,538,200.00 in 2020. Dr. Frost earned a salary of $960,000.00, and other compensation of $11,200.00.The highest earning executive at OPKO Health is Dr. Jon R. Cohen M.D., Sr. VP & Director, who commands a salary of $1,740,000.00 per year. Learn More on Phillip Frost's salary.
How do I contact Phillip Frost?
The corporate mailing address for Dr. Frost and other OPKO Health executives is 4400 BISCAYNE BLVD., MIAMI FL, 33137. OPKO Health can also be reached via phone at (305) 575-4100 and via email at mmiller@lhai.com. Learn More on Phillip Frost's contact information.
Has Phillip Frost been buying or selling shares of OPKO Health?
Who are OPKO Health's active insiders?
Are insiders buying or selling shares of OPKO Health?
In the last twelve months, OPKO Health insiders bought shares 21 times. They purchased a total of 3,514,600 shares worth more than $10,238,984.00. The most recent insider tranaction occured on June, 22nd when insider Gary J Nabel bought 240,000 shares worth more than $597,600.00. Insiders at OPKO Health own 41.0 % of the company.
Learn More about insider trades at OPKO Health. Information on this page was last updated on 6/22/2022.